Relative Strength Chart GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. 09:50:16 13/11/2026 +03			5-day change	1st Jan Change
2,673.00 ^INR	+0.67%		+5.87%	+8.18%

11-03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI
11-03	GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Sandeep Seth as Head - Ethics & Compliance, Effective November 3, 2026	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	Other Pharmaceuticals	+0.67%	+5.87%	+8.18%	+7.20%	+61.73%	4.78B